Esophagus, Stomach & Upper GI · Article 112

How Should Autoimmune Gastritis Be Diagnosed and Monitored?

Autoimmune gastritis requires a structured, evidence-based clinical approach. This review summarizes the key diagnostic, management, monitoring and decision points for gastroenterology and hepatology practice.

Autoimmune gastritis clinical reference — Related free clinical resource: Endoscopy and Diagnostic Imaging.

Autoimmune gastritis: practical clinical approach

This page focuses on Autoimmune gastritis with emphasis on decisions that change patient care, common pitfalls, and the current evidence base.

External guidance for Autoimmune gastritis

Clinical takeaway: For Autoimmune gastritis, decisions should integrate current guidelines, patient-specific risk, and the evidence summarized below.

Answer first: Autoimmune gastritis is a histologic diagnosis characterized by immune-mediated loss of oxyntic glands, typically producing corpus-predominant atrophy with relative antral sparing. Endoscopy should include systematic gastric mapping biopsies when the diagnosis is suspected. Check iron studies and vitamin B12, consider parietal-cell and intrinsic-factor antibodies as supportive tests, assess for associated autoimmune disease, and test for H. pylori. Surveillance is individualized because autoimmune gastritis increases the risk of gastric adenocarcinoma and type 1 gastric neuroendocrine tumors.

Think of autoimmune gastritis before pernicious anemia develops

Iron deficiency often appears before vitamin B12 deficiency because achlorhydria impairs iron absorption. Macrocytosis is therefore a late and insensitive clue. Suspicion should rise with unexplained iron deficiency, B12 deficiency, autoimmune thyroid disease or histology showing corpus-predominant atrophy.

Endoscopy and topographic biopsies establish the diagnosis

High-quality EGD should inspect the gastric mucosa carefully and obtain biopsies from antrum/incisura and corpus in separately labeled containers when atrophy is suspected. Histology demonstrates loss of oxyntic glands, intestinal/pseudopyloric metaplasia and enterochromaffin-like cell hyperplasia.

Laboratory assessment

Check CBC, ferritin/iron indices and vitamin B12. Parietal-cell antibodies are sensitive but not fully specific; intrinsic-factor antibodies are more specific but less sensitive. Hypergastrinemia reflects achlorhydria and contributes to type 1 gastric NET development.

Monitoring

Correct micronutrient deficiencies and screen for associated autoimmune thyroid disease. Endoscopic surveillance intervals are not perfectly defined and should reflect the severity/extent of atrophy, intestinal metaplasia, family history, geographic risk and presence of neuroendocrine tumors.

Practical clinical algorithm

Suspect autoimmune gastritis in unexplained iron/B12 deficiency or autoimmune disease.
Perform high-quality EGD with topographic gastric biopsies.
Confirm histologic corpus-predominant atrophy and exclude/identify H. pylori.
Check iron indices, vitamin B12 and supportive autoimmune serologies.
Screen for associated autoimmune thyroid disease.
Individualize surveillance for adenocarcinoma risk and screen specifically for type 1 gastric NETs.

Common mistakes to avoid

Waiting for pernicious anemia before considering the diagnosis.
Diagnosing autoimmune gastritis from antibodies alone.
Taking only antral biopsies.
Failing to look for iron deficiency.
Assuming H. pylori and autoimmune gastritis are mutually exclusive.

Trainee takeaway

Autoimmune gastritis is best recognized as a corpus-predominant atrophic process that causes micronutrient deficiency and neoplasia risk. Histology plus systematic clinical assessment is the foundation.

Frequently asked questions

Is pernicious anemia the same as autoimmune gastritis?

Pernicious anemia is a late manifestation of autoimmune gastritis with vitamin B12 deficiency; autoimmune gastritis can be present for years before anemia develops.

Do antibodies confirm the diagnosis?

They support the diagnosis, but histopathology is required to confirm atrophic gastritis.

Should these patients have thyroid testing?

Yes. Autoimmune thyroid disease is sufficiently common that screening is recommended.

References

1. Thomson ABR. First Principles of Gastroenterology and Hepatology in Adults and Children. 7th ed. CAPstone Academic Publishers; 2013.

2. Thomson ABR. Guideline-Based Management in Gastroenterology. CAPstone Academic Publishers; 2015.

3. Shah SC, Piazuelo MB, Kuipers EJ, Li D. AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis. Gastroenterology. 2021;161:1325-1332.e7.

4. Chey WD, Howden CW, Moss SF, et al. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2024;119:1730-1753.

Educational content only. Clinical decisions should incorporate the individual patient, local resources, product labeling, and the most current applicable guideline or regulatory information.

← Back to Clinical Questions